Assignee
TYME INC
US·16 granted patents·16 pending applications·67 citations·filing 2013–2022
Top patents by PatentIndex Score
32 records- 0198US10905698B1Methods of treating SARS-COV-2 infectionsTYME INC·Filed 2020·Granted Feb 2, 2021·8 cites·13 claims
- 0297US9895425B2Pharmaceutical compositions and methodsTYME INC·Filed 2016·Granted Feb 20, 2018·11 cites·31 claims
- 0396US10010590B2Pharmaceutical compositions and methodsTYME INC·Filed 2016·Granted Jul 3, 2018·9 cites·31 claims
- 0496US9549969B2Pharmaceutical compositions and methodsTYME INC·Filed 2015·Granted Jan 24, 2017·10 cites·11 claims
- 0593US10307465B2Pharmaceutical compositions and methodsTYME INC·Filed 2017·Granted Jun 4, 2019·4 cites·26 claims
- 0691US9724657B2High-speed centrifugal mixing devices and methods of useTYME INC·Filed 2013·Granted Aug 8, 2017·6 cites·25 claims
- 0790US11052068B2Pharmaceutical compositions and methodsTYME INC·Filed 2019·Granted Jul 6, 2021·2 cites·15 claims
- 0889US10646552B2Pharmaceutical compositions and methodsTYME INC·Filed 2019·Granted May 12, 2020·2 cites·31 claims
- 0988US10272068B2Pharmaceutical compositions and methodsTYME INC·Filed 2016·Granted Apr 30, 2019·5 cites·22 claims
- 1084US11097234B2High-speed centrifugal mixing devices and methods of useTYME INC·Filed 2017·Granted Aug 24, 2021·2 cites·19 claims
- 1183US10507198B2Pharmaceutical compositions and methodsTYME INC·Filed 2019·Granted Dec 17, 2019·2 cites·4 claims
- 1282US9585841B2Tyrosine derivatives and compositions comprising themTYME INC·Filed 2013·Granted Mar 7, 2017·4 cites·5 claims
- 1379US11058638B2Tyrosine derivatives and compositions comprising themTYME INC·Filed 2017·Granted Jul 13, 2021·2 cites·13 claims
- 1473US2021379014A1Pharmaceutical compositions and methodsTYME INC·Filed 2021·Application pending·0 cites
- 1571US11607418B2Methods of treating SARS-CoV-2 infectionsTYME INC·Filed 2021·Granted Mar 21, 2023·0 cites·15 claims
- 1670US2022313642A1Tyrosine derivatives and compositions comprising themTYME INC·Filed 2022·Application pending·0 cites
- 1766US11103559B2Pharmaceutical compositions and methodsTYME INC·Filed 2020·Granted Aug 31, 2021·0 cites·31 claims
- 1865US2020215082A1Dihydrotestosterone and Dihydrotestosterone Derivatives and Promoters in the Treatment of CancerTYME INC·Filed 2020·Application pending·0 cites
- 1961US11534420B2Compositions and methods for treating cancerTYME INC·Filed 2020·Granted Dec 27, 2022·0 cites·18 claims
- 2061US2020345753A1Pharmaceutical compositions for the treatment of cancerTYME INC·Filed 2020·Application pending·0 cites
- 2158US2021386832A1Pharmaceutical Compositions And MethodsTYME INC·Filed 2021·Application pending·0 cites
- 2256US2017080093A1Tyrosine Derivatives And Compositions Comprising ThemTYME INC·Filed 2016·Application pending·0 cites
- 2356US2018193360A1Dihydrotestosterone and Dihydrotestosterone Derivatives and Promoters in the Treatment of CancerTYME INC·Filed 2018·Application pending·0 cites
- 2455US2021169903A1Pharmaceutical compositions and methodsTYME INC·Filed 2020·Application pending·0 cites
- 2554US2017333451A1Dihydrotestosterone and dihydrotestosterone derivatives and promoters in the treatment of cancerTYME INC·Filed 2017·Application pending·0 cites
- 2654US2021220312A1Compositions And Methods For Modulating CancerTYME INC·Filed 2021·Application pending·0 cites
- 2754US2021106549A1Pharmaceutical compositions and methodsTYME INC·Filed 2020·Application pending·0 cites
- 2853US2021275467A1Tumor reduction formulations and methods of use thereofTYME INC·Filed 2019·Application pending·0 cites
- 2951US2020405680A1Transdermal formulationsTYME INC·Filed 2018·Application pending·0 cites
- 3048US2019091252A1Pharmaceutical compositions for the treatment of cancerTYME INC·Filed 2017·Application pending·0 cites
- 3144US2022002227A1Crystalline forms of metyrosineTYME INC·Filed 2021·Application pending·0 cites
- 3238US2022162154A1D-metyrosine compositions and methods for preparing sameTYME INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TYME INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →